About Chestnut Health Systems
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Chestnut Health Systems
During the past decade, Chestnut Health Systems conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study Evaluating HKI-272 (Neratinib) In Subjects With Advanced Breast Cancer
2006-08-04
2018-01-30
Completed
136
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
2007-02-05
2017-10-26
Completed
4,488
A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy.
2007-11-01
2010-01-01
Completed
360
Study Comparing Inotuzumab Ozogamicin In Combination With Rituximab Versus Defined Investigator's Choice In Follicular Non-Hodgkin's Lymphoma (NHL)
2007-11-01
2011-04-01
Terminated
29
Compare Bosutinib To Imatinib In Subjects With Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive CML
2008-02-05
2015-05-27
Completed
502
Study of Recombinant Factor IX Product, IB1001, in Subjects With Hemophilia B
2009-01-01
2016-12-01
Completed
77
Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First Relapse
2009-04-16
2013-04-12
Terminated
1,100
Safety, Efficacy and Pharmacokinetics of ALD518 in Patients With Non-Small Cell Lung Cancer-related Fatigue and Cachexia
2008-09-01
2009-12-01
Completed
124
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Chestnut Health Systems"
#1 collaborator was "National Institute on Drug Abuse (NIDA)" with 5 trials as a collaborator, "Columbia University" with 1 trials as a collaborator, "Cook County Sheriff's Women's Justice Services" with 1 trials as a collaborator, "Emory University" with 1 trials as a collaborator and "Haymarket Center" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were
collaborators in the rest 12 trials.
Clinical Trials Conditions at Chestnut Health Systems
According to Clinical.Site data, the most researched conditions in "Chestnut Health Systems" are
"Substance Use Disorders" (3 trials), "Schizophrenia" (2 trials), "Opioid-use Disorder" (1 trials), "Outcome Monitoring" (1 trials) and "Recovery" (1 trials). Many other conditions were trialed in "Chestnut Health Systems" in a lesser frequency.
Clinical Trials Intervention Types at Chestnut Health Systems
Most popular intervention types in "Chestnut Health Systems" are "Behavioral" (6 trials), "Other" (4 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "Any FDA approved antipsychotic agent" (1 trials), "Assertive Continuing Care (ACC)" (1 trials), "Chestnut Bloomington Outpatient (CBOP)" (1 trials), "Cognitive Adaptation Training" (1 trials) and "Community Treatment" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Chestnut Health Systems
The vast majority of trials in "Chestnut Health Systems" are
8 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Chestnut Health Systems
Currently, there are NaN active trials in "Chestnut Health Systems".
undefined are not yet recruiting,
3 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Chestnut Health Systems,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Chestnut Health Systems, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 5 trials that are defined as “Not Applicable".